Roche, the Swiss drug giant, will buy New York-based Flatiron Health, which has become a leader in applying big data approaches to medicine, for $1.9 billion. Roche already owned a 12% stake in Flatiron; in total the deal values Flatiron at $2.1 billion.
Flatiron was founded by Nat Turner and Zach Weinberg, two young entrepreneurs who had sold a previous company to Google for a reported $81 million and wanted to tackle something with more societal value. Turner, who was featured on Forbes 30 Under 30 list in 2015, will continue to lead Flatiron.
To read the entire article, please click on this https://www.forbes.com/sites/matthewherper/2018/02/15/roche-to-buy-big-data-upstart-flatiron-health-for-1-9-billion/
